Protein PRDM16 regulates human iPSC-derived cardiomyocyte maturation – potential target in heart damage repair & heart tissue engineering
Shortly after birth, the cells of the heart lose their ability to proliferate, becoming fully mature, life-long contractile cells. Indeed, it’s this lack of self-renewal capability that means any damage to the heart later in life (such as a heart attack), is likely to result in permanent scarring. Scientists have recently discovered a key developmental protein called PRDM16 that drives heart muscle cells to adopt and maintain their mature state. By experimentally increasing or decreasing the amount of PRDM16 in heart cells derived from human induced pluripotent stem cells (pictured), researchers found that the number of mature cells (coloured green) increased and decreased accordingly. These findings suggest that a short-lived inhibition of PRDM16 could become a strategy to treat heart damage, enabling heart cells at the injury site to temporarily repopulate, before they once again mature into fully functional integrated muscle.
Written by
BPoD stands for Biomedical Picture of the Day. Managed by the MRC Laboratory of Medical Sciences until Jul 2023, it is now run independently by a dedicated team of scientists and writers. The website aims to engage everyone, young and old, in the wonders of biology, and its influence on medicine. The ever-growing archive of more than 4000 research images documents over a decade of progress. Explore the collection and see what you discover. Images are kindly provided for inclusion on this website through the generosity of scientists across the globe.
BPoD is also available in Catalan at www.bpod.cat with translations by the University of Valencia.